Bordeaux Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$809K Sell
2,899
-6
-0.2% -$1.7K 0.1% 67
2025
Q1
$905K Buy
2,905
+152
+6% +$44.9K 0.17% 59
2024
Q4
$718K Sell
2,753
-200
-7% -$59.3K 0.12% 70
2024
Q3
$951K Buy
2,953
+218
+8% +$71.3K 0.17% 56
2024
Q2
$854K Buy
+2,735
New +$803K 0.16% 58
2021
Q3
Sell
-937
Closed -$228K 70
2021
Q2
$228K Buy
+937
New +$231K 0.13% 68

Other funds holding AMGN

Bordeaux Wealth Advisors's AMGN Position: Q2 2025 in Review

Bordeaux Wealth Advisors reduced its Amgen (AMGN) stake by 0.21% in Q2 2025, selling an estimated $1.7K and leaving 2,899 shares worth $809K. The position accounts for 0.1% of the portfolio, ranked #67.

Bordeaux Wealth Advisors first reported a position in AMGN in Q2 2021 and has held it in 6 quarters since. The position peaked at $951K in Q3 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Bordeaux Wealth Advisors held 2,899 shares of Amgen worth $809K as of Q2 2025.
  • Bordeaux Wealth Advisors sold 6 Amgen shares in Q2 2025, an estimated $1.7K.
  • Amgen made up 0.1% of Bordeaux Wealth Advisors's portfolio in Q2 2025, its #67 holding.
  • Bordeaux Wealth Advisors first reported a position in Amgen in Q2 2021 and has held it in 6 quarters since.
  • Bordeaux Wealth Advisors's Amgen position peaked at $951K in Q3 2024.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Bordeaux Wealth Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.